. Author manuscript; available in PMC: 2024 Feb 1.

Published in final edited form as: Pediatr Infect Dis J. 2022 Nov 2;42(2):152–158. doi: 10.1097/INF.0000000000003736

Table 4:

Outcomes of Serratia vs non-Serratia late-onset infection

	Serratia LOI			Non-Serratia LOI¹			Adjusted risk ratio (95% CI)²
	N	n	%	N	n	%
Survival to discharge	274	206	75.2	10,258	8,030	78.3	0.88 (0.82, 0.95)
Among survivors discharged home:
Tracheostomy placement	279	17	6.1	10,396	351	3.4	2.78 (1.68, 4.59)
Gastrostomy or jejunostomy placement	279	48	17.2	10,396	1,254	12.1	1.83 (1.41, 2.38)
Oxygen at discharge	166	75	45.2	6,730	2,529	37.6	1.29 (1.08, 1.54)
Human milk at discharge	174	46	26.4	6,792	2,538	37.4	0.64 (0.50, 0.83)

N: total number of infants with data available

n: number of infants with given characteristic among total

^1:

Includes all non-Serratia late bacterial LOI (including coagulase-negative Staphylococcus) and fungal LOI

^2:

Adjusted for clustering of infants within hospitals, and for gestational age in weeks, small for gestational age status, sex, mode of delivery, inborn status, and presence of a congenital anomaly